Live tape
Top 8, mentions 7d6,198NVDA1,021 mentions▲ +0.09NKE1,002 mentions+0.01GOOGL964 mentions▲ +0.04LULU955 mentions▲ +0.03TSLA856 mentions▲ +0.06META487 mentions▲ +0.04MSFT458 mentions▲ +0.07QQQ455 mentions▲ +0.08

Equity · Healthcare

ZBH

Zimmer Biomet Holdings, Inc. · NYSE

$99 −1.00% 1D Finazon · prior-day close · Sep 1, 2026
Price · Chart
Our own end-of-day closes 51 sessions
$110 $80 11 Jun 1 Sep

The line runs $87 on 11 June through $99 on 1 September, on a scale from $80 to $110. Days the market did not trade hold the previous close, flat.

The chart above plots the price of ZBH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 51 sessions over that window: $87 on 11 June 2026 through $99 on 1 September 2026.

Market cap $18.9B
P/E (TTM) 23.7
52-week range $79.56 – $107.59
Avg volume 419.3K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 8, 2026

ZBH insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 1 Aug 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 2

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Aug 2026 Thornal Kevin R Grp Pres-Global Business Option exercise 9,957
01 Aug 2026 Thornal Kevin R Grp Pres-Global Business Tax withheld 4,266 $395K

ZBH reported financials

SEC EDGAR XBRL

ZBH reported revenue of $8.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $705.1M.

Figure Reported Period
Revenue $8.2B 31 Dec 2025 fiscal year
Net income $705.1M 31 Dec 2025 fiscal year
Diluted EPS $3.55 31 Dec 2025 fiscal year
Total assets $22.8B 30 Jun 2026 at period end
Total equity $12.6B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

ZBH earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.03 $2.18B
31 Mar 2026 Q1 2026 $1.22 $2.09B
31 Dec 2025 FY 2025 $3.55 $8.23B
30 Sep 2025 Q3 2025 $1.16 $2.00B
30 Jun 2025 Q2 2025 $0.77 $2.08B
31 Mar 2025 Q1 2025 $0.91 $1.91B
31 Dec 2024 FY 2024 $4.43 $7.68B
30 Sep 2024 Q3 2024 $1.23 $1.82B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ZBH institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a ZBH position for the quarter ended 30 Jun 2026 — a combined $473.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Citadel Advisors Added +152.2% shares 3,477,472 $299.4M
Point72 Asset Management New position 879,851 $75.7M
AQR Capital Management Held (±25%) +12.2% shares 367,365 $31.3M
GAMCO Investors Held (±25%) −1.1% shares 228,658 $19.7M
Millennium Management New position 222,065 $19.1M
Marshall Wace New position 144,500 $12.4M
Tudor Investment Corp New position 71,996 $6.2M
Two Sigma Investments Added +55.7% shares 49,754 $4.3M
Bridgewater Associates Held (±25%) +6.3% shares 36,150 $3.1M
D. E. Shaw & Co. Added +163.7% shares 24,120 $2.1M

Source: SEC EDGAR 13F filings

ZBH fails-to-deliver

SEC CNS data

On 29 Jul 2026, 1,270 shares of ZBH failed to deliver (about $122K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
29 Jul 2026 1,270 $122K 0.001%
28 Jul 2026 24,855 $2.3M 0.013%

Source: SEC fails-to-deliver (CNS) data